Related Experiment Video
Updated: May 10, 2026
11:28
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
3D-fection: cell transfection within 3D scaffolds and hydrogels
Cédric Sapet1, Cécile Formosa, Flavie Sicard
1Parc Scientifique de Luminy - Zone Entreprise, Marseille cedex 9, France. nlaurent@ozbiosciences.com
Therapeutic Delivery
|June 7, 2013
Summary
Two novel non-viral transfection reagents, 3D-Fect™ and 3D-FectIN™, enable in situ genetic manipulation of cells within 3D matrices. This advancement supports applications in regenerative medicine and drug assays without pre-seeding cell manipulation.
Area of Science:
- Biotechnology
- Cell Biology
- Materials Science
Background:
- 3D matrices are crucial for cell culture in research, regenerative medicine, and drug assays.
- Genetic manipulation of cells within these matrices is challenging.
Purpose of the Study:
- To evaluate two novel non-viral transfection reagents for in situ cell transfection within 3D matrices.
- To assess the compatibility and efficacy of these reagents for genetic modification of various cell types.
Main Methods:
- Assessment of 3D-Fect™ for solid scaffolds and 3D-FectIN™ for hydrogels.
- Transfection of classical cell lines, primary cells, and stem cells within their 3D growth environments.
Main Results:
- Both reagents demonstrated compatibility with common 3D matrices.
- Successful transfection of diverse mammalian cells, including stem cells, was achieved.
- The in situ transfection strategy eliminated the need for pre-seeding cell manipulation.
Conclusions:
- 3D-Fect™ and 3D-FectIN™ are compatible with cells and do not compromise matrix properties.
- These reagents facilitate localized and sustained transgene expression.
- They offer versatile applications in fundamental research, regenerative medicine, and cell-based drug assays.
